Physician profile
Tomas G Antonini
NPI 1265494827
$183,344.70
in general payments reported to CMS, 2019-2025
47 companies · $30K in 2025
The $30K reported for 2025 was more than what 98% of Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) providers received nationally (typical 2025 total: $413).
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $35K · 2020: $42K · 2021: $25K · 2022: $21K · 2023: $5,825 · 2024: $25K · 2025: $30K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $36K · Travel and Lodging: $15K · Food and Beverage: $9,865 · Entertainment: $181 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $35,641.66 |
| Travel and Lodging | $14,954.87 |
| Food and Beverage | $9,865.27 |
| Entertainment | $180.93 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $136,434.14 | 2019-2025 | Altis, Saffron, Speedicath |
| Intuitive Surgical, INC. | $25,117.42 | 2020-2025 | |
| Ethicon INC. | $6,500.00 | 2024-2025 | |
| Axonics, INC. | $3,967.39 | 2020-2024 | Axonics, Bulkamid |
| Medtronic, INC. | $2,456.41 | 2022-2025 | Interstim, Altaviva |
| Caldera Medical, INC | $1,398.88 | 2019-2023 | Desara |
| Allergan, INC. | $1,293.81 | 2019-2022 | |
| Abbvie INC. | $1,198.30 | 2019-2025 | Botox, Lo Loestrin Fe |
| Sumitomo Pharma America, INC. | $1,133.39 | 2023-2025 | Gemtesa, Myfembree |
| Ethicon Endo-Surgery INC. | $550.00 | 2022 | |
| Biotissue Holdings INC. | $440.71 | 2025 | |
| Boston Scientific Corporation | $385.09 | 2019-2025 | Axonics, Solyx Sis System |
| Astellas Pharma US INC | $207.99 | 2022-2024 | Veozah |
| Tela Bio, INC. | $206.49 | 2021-2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Bluewind Medical | $173.13 | 2024-2025 | Revi |
Show all 47 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $154.23 | 2022-2025 | |
| Exeltis, USA INC. | $138.65 | 2023-2025 | Slynd, Twirla |
| Therapeuticsmd, INC. | $127.94 | 2019-2022 | |
| Myovant Sciences INC. | $125.15 | 2021-2022 | |
| Millicent US INC | $117.03 | 2020-2025 | Intrarosa, Femlyv |
| Convatec INC. | $116.53 | 2024 | |
| 180 Medical, INC. | $105.34 | 2022-2023 | Cure Catheter |
| Medtronic USA, INC. | $97.41 | 2019-2020 | |
| Valencia Technologies Corporation | $93.90 | 2025 | Ecoin Device Kit |
| Davol INC. | $93.33 | 2024-2025 | Arista, Arista Ah Flexitip |
| Shield Therapeutics INC | $82.14 | 2024 | |
| Zyla Life Sciences, INC. | $70.57 | 2020 | |
| Integra Lifesciences Corporation | $64.50 | 2023-2025 | Integra, Surgimend, Integra Dermal Regeneration Template |
| Amag Pharmaceuticals, INC. | $46.99 | 2019-2020 | |
| Stryker Corporation | $40.88 | 2025 | Alphavent |
| Lupin INC. | $37.58 | 2020-2021 | |
| Evofem Biosciences, INC. | $36.78 | 2021-2025 | Phexxi, Solosec, Phexx |
| Smith+Nephew, INC. | $34.84 | 2023 | Stravix Pl |
| Lsi Solutions INC | $33.13 | 2020 | |
| Ascend Therapeutics US, LLC | $29.78 | 2022-2023 | |
| Coopersurgical, INC. | $29.39 | 2020 | |
| Hologic Sales and Service, LLC | $25.80 | 2025 | Novasure, Myosure Tissue Removal Device, Omni Hysteroscope |
| Dilon Technologies, INC. | $24.61 | 2025 | Hemoblast Bellows |
| Avanos Medical | $22.04 | 2022 | |
| Gynesonics, INC. | $21.40 | 2022 | |
| Becton, Dickinson and Company | $21.22 | 2024 | Arista Ah Flexitip |
| Conmed Corporation | $18.01 | 2021 | |
| Aspira Women'S Health INC | $15.87 | 2024 | Ova1 |
| Heron Therapeutics, INC. | $14.72 | 2022 | |
| Virtus Pharmaceuticals LLC | $14.67 | 2021 | |
| Vertical Pharmaceuticals, LLC | $13.62 | 2019 | |
| Escala Medical INC. | $13.50 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$818.00 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tomas Antonini listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.